openPR Logo
Press release

Advancement in the Biopharmaceutical Industry Along with Plasma Protein Therapies will Boost the Protein Fractionation Market

05-23-2017 03:54 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Advancement in the Biopharmaceutical Industry Along with

Protein fractionation referred as a process of separation or purification of single or multiple proteinfrom complex mixture of protein based on differences in a specific property of individual component. It is a major step in Proteomics, which is a science of protein analysis. Key limitation of protein and peptide analysis is their heterogenicity in terms of their physiochemical properties. Hence, the protein fractionation technique is very useful tool for protein analysis in various field such as life sciences, and food sciences. Fractionation makes it possible to separate more than two components in a single run. This property sets it apart from other separation techniques.Technological advancement led to high throughput, more resolution, and enhanced sensitivity in the protein fractionation as well as at other stages of protein analysis.

Browse through Protein Fractionation Market report to know what factors will shape the market by 2023: http://www.transparencymarketresearch.com/protein-fractionation-market.html

The global protein fractionation market segmented based on principle of protein fractionation: fractionation by solubility, by cellular location, by charge, by size and fraction by isoelectric point (pI). Geographically, the market segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America market was highest market in 2014 due to development of advanced technique for protein fractionation, and well established biopharmaceutical and food industry.However, Asia Pacific and Latin America expected to grow at the faster rate due to growing research base activities primarily in the drug discovery and development area. Protein fractionation by size market dominated in2014 due to application of principle in various techniques, and development of chromatography technique.

Fractionation based on solubility kits separate the protein based on proteins solubility nature and procedure generally involved in this are salt precipitation and detergent solubilization. Kits that separate proteins based on their cellular location are available and separates the protein based on their cell location such as cytoplasm and nuclear protein, membrane proteins, and proteins involved in intracellular membrane signaling pathway and trafficking. Fractionation by charge kits separates the sample, which enriched with the selectively acidic or basic proteins. This separation carried out by ion exchange, electrophoresis, and isoelectric focusing method. Size based fractionation can carried out by dialysis, ultracentrifugation, gel electrophoresis, and gel filtration techniques. Differences in the isoelectric point of protein would be helpful to fractionate the proteins.

The major market drivers for global protein fractionation are increase in the proteomics activities, growing outsourcing of proteomics services, advancement in the biopharmaceutical industry along with plasma protein therapies, and increase in the government and private funding in the emerging countries.Additionally, emergence of new market player boosts the protein fractionation market. However, lower investment by U.S. government in researchactivities to support proteomics would restrict the U.S. as well as global market. Additionally, high cost of advanced instruments, and difficulties to proteomics companies to gain the approval are other restricting factors of global protein fractionation industry. Opportunities for this market lie in the Asian and Latin America market where contract research organization are on high and less regulations than U.S. and Europe.

Get accurate market forecast and analysis on the Protein Fractionation Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8179

Number of companies in the protein fractionation field increased in past few years. However, Major global players in the protein fractionation market are Thermo Fisher Scientific Corporation, Agilent Technologies, and Bio-Rad Laboratories. These companies take the maximum share of the global market. Other players include GE Healthcare Lifesciences, Danaher Corporation, Waters Corporation, PerkinElmer, Luminex, Sigma Aldrich Corporation, and Affymetrix, Inc.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Advancement in the Biopharmaceutical Industry Along with Plasma Protein Therapies will Boost the Protein Fractionation Market here

News-ID: 547768 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Fractionation

Plasma Fractionation Market 2021 | Detailed Report
The Plasma Fractionation research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Plasma Fractionation research report offers information and thoughtful facts like share, revenue, historical data, and global market share. It also highlights vital aspects like opportunities, driving, product scope, market overview, and driving force. Get Free Sample PDF (including full
Plasma Fractionation Market Report Up to 2031
Visiongain has published a new report on Plasma Fractionation Market Report 2021-2031: Forecasts by Product (IVIG, Albumin, Factor VIII, von Willebrand Factor, PCC, Protease Inhibitor), Application (Immunology, Haematology, Critical Care, Rheumatology, Pulmonology), End User (Hospitals & Clinics). PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios. Download Exclusive Sample of Report @ https://www.visiongain.com/report/plasma-fractionation-market-2021/#download_sampe_div Market growth is driven primarily by factors such as
Plasma Fractionation Market continues to expand with Grifols S.A. acquiring GC P …
Plasma fractionation refers to the medical practices of separating the antigens from the plasma of red blood cells, which in turn results in the formation of plasma. This separation results in higher concentrations of antigens than those found in whole blood. Plasma fractionation also leads to more efficient processing of drugs. Over the years, immunoglobulin has been used in the treatment of various diseases including lupus, myositis, chronic inflammatory demyelinating
Plasma Fractionation Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Plasma Fractionation Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 102 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-plasma-fractionation-market_p107737.html   Human blood plasma is nature's raw material for
Plasma Fractionation Market Regional Analysis by 2025
Global Plasma Fractionation Market: Overview The global plasma fractionation market is envisaged to develop at a brisk pace owing to the rising geriatric population all over the world. This is mainly due to the surging use of immunoglobins for various therapeutic treatment processes undertaken for providing adequate healthcare to elderly people. Global Plasma Fractionation Market: Key Drivers and Restraints A rise in healthcare awareness amongst people all over the world has been a
Global Blood Plasma Fractionation Sales Market Report 2017
MarketResearchReports.Biz presents this most up-to-date research on "Global Blood Plasma Fractionation Sales Market Report 2017" Description In this report, the global Blood Plasma Fractionation market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market